[ad_1] – Encouraging preliminary anti-tumor activity observed in heavily pre-treated population – – At ≥ 90 mg QD, 6 out of 11 (54.5%) patients with FGFR3+ mUC achieved a confirmed partial response (PR), with 100% […]